title: Neuronal nicotinic receptor inhibition for treating mood disorders: preliminary controlled evidence with mecamylamine.
authors.affiliation: Center for Aging and Brain Repair, Department of Neurosurgery, University of South Florida College of Medicine, 12901 Bruce B. Downs Boulevard, Tampa, FL 33613, USA. dshytle@hsc.usf.edu
authors.forename: R Douglas
authors.initials: RD
authors.lastname: Shytle
authors.forename: Archie A
authors.initials: AA
authors.lastname: Silver
authors.forename: Kathy H
authors.initials: KH
authors.lastname: Sheehan
authors.forename: David V
authors.initials: DV
authors.lastname: Sheehan
authors.forename: Paul R
authors.initials: PR
authors.lastname: Sanberg
mesh_terms: D000293:Adolescent; D001289:Attention Deficit Disorder with Hyperactivity / Q000523:psychology; D002648:Child; D003865:Major Depressive Disorder / Q000188:drug therapy* / Q000209:etiology; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008464:Mecamylamine / Q000494:pharmacology* / Q000627:therapeutic use*; D009474:Neurons / Q000187:drug effects*; D018733:Nicotinic Antagonists / Q000494:pharmacology* / Q000627:therapeutic use*; D011978:Receptors, Nicotinic / Q000187:drug effects*; D005879:Tourette Syndrome / Q000523:psychology
chemical_list: D018733:Nicotinic Antagonists; D011978:Receptors, Nicotinic; D008464:Mecamylamine